Condensed five-membered heterocyclic compounds

摘要

The invention relates to fused 5-membered heterocycles of the general formula in which Ra, Rb, X and Y are as defined in Claim 1, their tautomers, their stereoisomers including their mixtures and their salts, in particular their physiologically tolerated salts with inorganic or organic acids or bases, which have valuable pharmacological properties, preferably aggregation-inhibiting actions, to pharmaceutical compositions containing the compounds and to processes for the preparation thereof.